IP2IPO Group, which specialises in commercialising university technology, has made an exclusive 25-year deal with the University of Bristol to form spin-out companies from the university. Analysts greeted the deal as a boost for the company.

A Swiss team has developed a reliable blood test for younger, live cows. Now it is looking for investment to develop a test for Creutzfeldt-Jakob disease in humans.

Microsoft is to open more research centres in Europe, in a move to step up its research collaboration and boost students' interest in the technology field.

"Anything that won't sell, I don't want to invent. Its sale is proof of utility, and utility is success." Thomas A. Edison (1847-1931).

A British pharmaceutical distributor, Beckpharma Ltd., said it licensed two Cuban healthcare products to sell in Europe as part of a broader effort for trade links.

A British start-up is betting it has a better way for television networks to watch their viewers watching them.

A politician's gaffe highlights the gender gap in science. Political action, not talk, is what's needed to close it.

We interview Andrew Newland, head of a venture capital consultancy with a long-term strategy of working with scientists and inventors.